Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
GLP-1 receptor agonists in type 2 diabetes : paradoxical real-life underuse in patients with atherosclerotic cardiovascular diseaseRevue médicale de Liège, 2024-03, Vol.79 (3), p.146-151 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 38487908Full text available |
2 |
Material Type: Article
|
![]() |
Blood pressure variability : useful, trivial or potentially dangerous ?Revue médicale de Liège, 2023-04, Vol.78 (4), p.204 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 37067837Full text available |
3 |
Material Type: Article
|
![]() |
Fixed combination atorvastatin-perindopril (Lipercosyl®) for substitution treatment of cardiovascular risk managementRevue médicale de Liège, 2021-02, Vol.76 (2), p.128 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 33543860Full text available |
4 |
Material Type: Article
|
![]() |
Don't neglect metabolic syndromeRevue médicale de Liège, 2024-03, Vol.79 (3), p.191-194 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 38487915Full text available |
5 |
Material Type: Article
|
![]() |
Patient with type 2 diabetes and coronary heart disease developing heart failureRevue médicale de Liège, 2024-04, Vol.79 (4), p.260-264 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 38602215Full text available |
6 |
Material Type: Article
|
![]() |
CARDIOVASCULAR INVOLVEMENTS IN BEHÇET'S DISEASE: "ANGIO-BEHÇET"Revue médicale de Liège, 2016-01, Vol.71 (1), p.22-27 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 26983310Full text available |
7 |
Material Type: Article
|
![]() |
EMPA-KIDNEY: empagliflozin in chronic kidney diseaseRevue médicale de Liège, 2023-01, Vol.78 (1), p.24 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 36634063Full text available |
8 |
Material Type: Article
|
![]() |
Lipertance® The ASCOT single-pill combination has finally arrivedRevue médicale de Liège, 2017-09, Vol.72 (9), p.416-422 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 28892318Full text available |
9 |
Material Type: Article
|
![]() |
Inclisiran (Leqvio®), a potent cholesterol-lowering agent by inhibiting PCSK9 using small interfering RNA-based innovative therapyRevue médicale de Liège, 2022-12, Vol.77 (12), p.745 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 36484754Full text available |
10 |
Material Type: Article
|
![]() |
SGLT2 inhibitor or GLP-1 receptor agonist in a patient with type 2 diabetes and cardiovascular disease ?Revue médicale de Liège, 2018-01, Vol.73 (1), p.43-50 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 29388411Full text available |
11 |
Material Type: Article
|
![]() |
Complementarity between randomised controlled trials and observational registries : the example of cardiovascular prevention with SGLT2 inhibitorsRevue médicale de Liège, 2017-12, Vol.72 (12), p.563-568 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 29271137Full text available |
12 |
Material Type: Article
|
![]() |
COVID-19 andcardiovascular diseasesRevue médicale de Liège, 2020-04, Vol.75 (4), p.226-232 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 32267110Full text available |
13 |
Material Type: Article
|
![]() |
EHLERS-DANLOS SYNDROME OF THE HYPERMOBILE TYPE: A MULTISYSTEMIC DISORDER. CONTRIBUTION OF SKIN ULTRASTRUCTURE TO INDIVIDUAL MANAGEMENTRevue médicale de Liège, 2015-05, Vol.70 (5-6), p.325-330 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 26285461Full text available |
14 |
Material Type: Article
|
![]() |
My pet, a safeguard for my healthRevue médicale de Liège, 2013-11, Vol.68 (11), p.569-573 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 24396970Full text available |
15 |
Material Type: Article
|
![]() |
HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASESRevue médicale de Liège, 2016-05, Vol.71 (5), p.262-268 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 27337847Full text available |
16 |
Material Type: Article
|
![]() |
Levels of target achievement for major modifiable cardiovascular risk factors in BelgiumRevue médicale de Liège, 2014-04, Vol.69 (4), p.200-209 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 24923100Full text available |
17 |
Material Type: Article
|
![]() |
FIXED COMBINATION ATORVASTATIN-EZETIMIBE (ATOZET®)Revue médicale de Liège, 2016-01, Vol.71 (1), p.47-52 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 26983314Full text available |
18 |
Material Type: Article
|
![]() |
Focus on empagliflozin : post hoc analyses of the cardiovascular outcome trial EMPA-REG OUTCOMERevue médicale de Liège, 2019-04, Vol.74 (4), p.185-191 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 30997967Full text available |
19 |
Material Type: Article
|
![]() |
EMPA-REG OUTCOME: Empagliflozin reduces mortality in patients with type 2 diabetes at high cardiovascular riskRevue médicale de Liège, 2015-11, Vol.70 (11), p.583-589 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 26738271Full text available |
20 |
Material Type: Article
|
![]() |
European guidelines for the management of diabetes, prediabeties and cardiovascular disease. First part. Management of diabetes and cardiovascular risk factorsRevue médicale de Liège, 2013-11, Vol.68 (11), p.585-592 [Peer Reviewed Journal]ISSN: 0370-629X ;PMID: 24396973Full text available |